Prices delayed by at least 15 minutes | Print
Global X Etfs Icav GLOBAL X TELEMED & DIGTL HLTH UCITS ETF (EDOG)
Open
£6.405
Previous close
£6.323
Trade high
£6.421
Income frequency
Semi-annually
Year low
£4.8655
Year high
£7.262
Replication method
Physical Full
Volume
5
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.68
ISIN
IE00BLR6QC17
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Before investing please read:
Share price
Asset allocation
Top 10 holdings
| Holdings 11/12/2025 | % of assets |
|---|---|
| Illumina Inc | 5.88 |
| Veracyte Inc | 4.88 |
| Labcorp Holdings Inc | 4.37 |
| Quest Diagnostics Inc | 4.25 |
| IQVIA Holdings Inc | 4.25 |
| DexCom Inc | 4.14 |
| Agilent Technologies Inc | 4.08 |
| ResMed Inc | 4.07 |
| Masimo Corp | 4.04 |
| Privia Health Group Inc | 3.97 |
Investment objective
The investment objective of the Fund is to provide investment results that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Telemedicine & Digital Health Index (the “Index”).
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.
Asset class
ETFMorningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.